本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Ligand Pharmaceuticals Inc.

284.47
-4.7800-1.65%
盤後284.470.00000.00%19:57 EDT
成交量:26.12萬
成交額:7,458.64萬
市值:56.71億
市盈率:29.30
高:294.00
開:291.48
低:283.77
收:289.25
52周最高:326.63
52周最低:161.82
股本:1,993.56萬
流通股本:1,935.39萬
量比:1.31
換手率:1.35%
股息:- -
股息率:- -
每股收益(TTM):9.71
每股收益(LYR):6.13
淨資產收益率:21.96%
總資產收益率:3.99%
市淨率:5.86
市盈率(LYR):46.41

資料載入中...

2026/09/11

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/09/04

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/09/02

重要事件披露

Form 8-K/A - Current report: [Amend]
2026/08/13

超過5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/08/13

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/08/12

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/08/07

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2026/08/06

重要事件披露

Form 8-K - Current report
2026/07/22

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2026/07/14

重要事件披露

Form 8-K - Current report
2026/07/01

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/06/25

重要事件披露

Form 8-K - Current report
2026/06/22

重要事件披露

Form 8-K - Current report
2026/06/16

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/06/12

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/06/11

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/06/10

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/06/10

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/06/10

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/06/09

重要事件披露

Form 8-K - Current report